A phase III randomized, open-label, non-inferiority clinical trial comparing liquid and lyophilized formulations of oral live attenuated human rotavirus vaccine (HRV) in Indian infants

The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6–10 weeks received 2 doses (1 month apart) of either Liq...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohet, Catherine, Cheuvart, Brigitte, Moerman, Leentje, Bi, Dan, Caplanusi, Adrian, Kariyappa, Mallesh, Lalwani, Sanjay, Mitra, Monjori, Sapru, Amita, Saha, Shruti, Varughese, P.V., Kompithra, Rajeev Zachariah, Gandhi, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828117/
https://www.ncbi.nlm.nih.gov/pubmed/34428112
http://dx.doi.org/10.1080/21645515.2021.1960136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828117/
https://www.ncbi.nlm.nih.gov/pubmed/34428112
http://dx.doi.org/10.1080/21645515.2021.1960136

Ejemplares similares